Overview Financials News + Filings Key Docs Charts Ownership
|
In millions, except per share items | Dec-31-20 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | S-1/A |
Revenues: |
Export | | | | 2,836.4 | 3,930.9 | 5,037.7 | 4,193.1 | 2,561.3 |
CIS | | | | 647.8 | 996.8 | 1,047.5 | 646.4 | 277.8 |
Middle East | | | | 265.7 | 667.1 | 912.7 | 908.7 | 585.4 |
Other regions | | | | 97.7 | 201.3 | 375.8 | 179.7 | 94.7 |
Other | | | | 4,658.3 | 4,957.5 | 4,913.7 | 3,818.8 | 2,234.9 |
Total revenues | 0.0 | 100.0 | 100.0 | 8,505.9 | 10,753.5 | 12,287.3 | 9,746.6 | 5,754.1 |
Revenue growth [+] | | 0.0% | -98.8% | -20.9% | -12.5% | 26.1% | 69.4% | -42.2% |
Export | | | | -27.8% | -22.0% | 20.1% | 63.7% | |
CIS | | | | -35.0% | -4.8% | 62.1% | 132.7% | |
Middle East | | | | -60.2% | -26.9% | 0.4% | 55.2% | |
Other regions | | | | -51.5% | -46.4% | 109.1% | 89.8% | |
Russia entities | | | | -13.9% | -4.1% | 20.9% | | |
Cost of goods sold | 0.0 | 59.8 | 62.7 | 5,698.9 | 7,262.8 | 7,791.7 | 6,015.9 | 3,942.5 |
Gross profit | 0.0 | 40.2 | 37.3 | 2,807.0 | 3,490.7 | 4,495.6 | 3,730.8 | 1,811.7 |
Gross margin | | 40.2% | 37.3% | 33.0% | 32.5% | 36.6% | 38.3% | 31.5% |
Selling, general and administrative [+] | | 30.7 | 36.9 | 2,230.5 | 2,217.4 | 2,288.9 | 1,918.2 | 1,452.3 |
Sales and marketing | | | | 1,720.4 | 1,710.6 | 1,705.7 | 1,435.2 | 1,062.8 |
General and administrative | 0.0 | | | 510.1 | 506.8 | 583.2 | 483.0 | 389.5 |
Equity in earnings | | | | 3.6 | 0.5 | 0.3 | 1.2 | 1.2 |
Other operating expenses | | | | 1,019.6 | 1,264.9 | 319.5 | 271.2 | 92.8 |
EBITDA [+] | | 12,406.5 | 12,639.4 | -76.2 | 372.3 | 2,229.3 | 1,870.8 | 588.9 |
EBITDA growth | | -1.8% | -16680.0% | -120.5% | -83.3% | 19.2% | 217.7% | -79.8% |
EBITDA margin | | 12406.5% | 12639.4% | -0.9% | 3.5% | 18.1% | 19.2% | 10.2% |
Depreciation and amortization | | 12,397.0 | 12,639.0 | 366.9 | 363.9 | 341.9 | 329.4 | 321.1 |
EBIT [+] | 0.0 | 9.5 | 0.4 | -443.1 | 8.4 | 1,887.4 | 1,541.4 | 267.8 |
EBIT growth | | 2275.0% | -100.1% | -5390.5% | -99.6% | 22.5% | 475.6% | -89.5% |
EBIT margin | | 9.5% | 0.4% | -5.2% | 0.1% | 15.4% | 15.8% | 4.7% |
Non-recurring items [+] | | | | 213.7 | 606.0 | 8.9 | 9.1 | 20.9 |
Asset impairment | | | | 215.7 | 607.9 | 10.6 | 10.8 | 20.9 |
Interest expense, net [+] | | | | 796.0 | 579.6 | 534.5 | 541.1 | 477.5 |
Interest expense | | | | 803.3 | 649.8 | 551.3 | 558.3 | 499.0 |
Interest income | | | | 7.3 | 70.2 | 16.8 | 17.2 | 21.4 |
Other income (expense), net [+] | | -9.5 | -0.4 | -173.0 | 141.1 | -146.3 | -21.9 | 325.9 |
Gain (loss) on foreign currency transactions | | | | -164.8 | 107.5 | -142.0 | -14.5 | -174.3 |
Other | | -51.8 | -54.1 | -74.6 | 33.1 | -4.4 | -8.5 | 500.3 |
Pre-tax income | 0.0 | 0.0 | 0.0 | -1,625.8 | -1,036.1 | 1,197.7 | 969.2 | 95.2 |
Income taxes | 0.0 | 3.3 | -3.6 | 79.1 | 242.6 | 366.2 | 276.6 | 18.9 |
Tax rate | | | | | | 30.6% | 28.5% | 19.8% |
Minority interest | | | | -5.0 | 0.3 | 75.6 | -34.8 | 2.6 |
Earnings from continuing ops | | | | -1,710.0 | -1,357.4 | 677.6 | 649.0 | -60.8 |
Earnings from discontinued ops | | | | -1,218.1 | -386.2 | -28.0 | -0.6 | |
Net income | 0.0 | 0.0 | 0.0 | -2,928.1 | -1,743.6 | 649.6 | 648.4 | -60.8 |
Net margin | | 0.0% | 0.0% | -34.4% | -16.2% | 5.3% | 6.7% | -1.1% |
|
Basic EPS [+] | | | | ($4.11) | ($3.26) | $1.63 | $1.56 | ($0.15) |
Growth | | | | 26.0% | -300.3% | 4.4% | -1168.2% | -105.3% |
Diluted EPS [+] | | | | ($4.11) | ($3.26) | $1.63 | $1.56 | ($0.15) |
Growth | | | | 26.0% | -300.3% | 4.4% | -1168.2% | -105.3% |
|
Dividends per share [+] | | | | $0.00 | $0.45 | $0.51 | $0.06 | $0.50 |
Growth | | | | -99.9% | -11.3% | 801.3% | -88.8% | -55.5% |
|
Shares outstanding (basic) | | | | 416.3 | 416.3 | 416.3 | 416.3 | 416.3 |
Growth | | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Shares outstanding (diluted) | | | | 416.3 | 416.3 | 416.3 | 416.3 | 416.3 |
Growth | | | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|